Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,588 Cr
down ₹31.8 Cr vs Jul 2022
- Stocks held
- 28
- up 1 vs Jul 2022
- Top 10 weight
- 69.0%
- of the portfolio in its ten largest
- Cash & debt
- 0.3%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 14
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In August 2022 it disclosed 28 stocks worth ₹4,588 Cr, down ₹31.8 Cr from Jul 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.2%), Cipla Limited (9.1%), Dr. Reddy's Laboratories Limited (7.9%); the ten largest together made up 69.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 80.6% of its equity. Cash and debt stood at 0.3%. Compared with Jul 2022 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
4%
Holds more cash than 4% of peers
Holdings in August 2022
Download CSVEvery line the fund disclosed, with the change against Jul 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.21%
- Δ weight
- down 0.69 pts
- Value
- ₹652 Cr
- Δ value
- down ₹36.6 Cr
- Status
- Trimmed
- Weight
- 9.05%
- Δ weight
- up 0.59 pts
- Value
- ₹415 Cr
- Δ value
- up ₹24.4 Cr
- Status
- Added
- Weight
- 7.87%
- Δ weight
- up 0.34 pts
- Value
- ₹361 Cr
- Δ value
- up ₹13.1 Cr
- Status
- Added
- Weight
- 6.56%
- Δ weight
- up 0.57 pts
- Value
- ₹301 Cr
- Δ value
- up ₹24.1 Cr
- Status
- Added
- Weight
- 6.42%
- Δ weight
- down 0.05 pts
- Value
- ₹295 Cr
- Δ value
- down ₹4.6 Cr
- Status
- Trimmed
- Weight
- 5.93%
- Δ weight
- down 1.54 pts
- Value
- ₹272 Cr
- Δ value
- down ₹73.2 Cr
- Status
- Trimmed
- Weight
- 5.64%
- Δ weight
- down 0.10 pts
- Value
- ₹259 Cr
- Δ value
- down ₹6.6 Cr
- Status
- Trimmed
- Weight
- 5.28%
- Δ weight
- down 0.32 pts
- Value
- ₹242 Cr
- Δ value
- down ₹16.5 Cr
- Status
- Trimmed
- Weight
- 4.16%
- Δ weight
- up 0.02 pts
- Value
- ₹191 Cr
- Δ value
- down ₹56 L
- Status
- Held
- Weight
- 3.85%
- Δ weight
- down 0.07 pts
- Value
- ₹177 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 3.29%
- Δ weight
- up 0.05 pts
- Value
- ₹151 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 3.10%
- Δ weight
- up 0.16 pts
- Value
- ₹142 Cr
- Δ value
- up ₹6.4 Cr
- Status
- Added
- Weight
- 3.00%
- Δ weight
- down 0.05 pts
- Value
- ₹138 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- up 0.09 pts
- Value
- ₹130 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 2.52%
- Δ weight
- up 0.67 pts
- Value
- ₹115 Cr
- Δ value
- up ₹30.1 Cr
- Status
- Added
- Weight
- 2.45%
- Δ weight
- up 0.02 pts
- Value
- ₹112 Cr
- Δ value
- up ₹13 L
- Status
- Held
- Weight
- 2.38%
- Δ weight
- down 0.06 pts
- Value
- ₹109 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 2.15%
- Δ weight
- up 0.52 pts
- Value
- ₹98.7 Cr
- Δ value
- up ₹23.2 Cr
- Status
- Added
- Weight
- 1.83%
- Δ weight
- down 0.14 pts
- Value
- ₹84 Cr
- Δ value
- down ₹7.1 Cr
- Status
- Trimmed
- Weight
- 1.52%
- Δ weight
- up 0.10 pts
- Value
- ₹69.7 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 1.43%
- Δ weight
- down 0.10 pts
- Value
- ₹65.8 Cr
- Δ value
- down ₹4.9 Cr
- Status
- Trimmed
- Weight
- 0.99%
- Δ weight
- down 0.10 pts
- Value
- ₹45.3 Cr
- Δ value
- down ₹4.8 Cr
- Status
- Trimmed
- Weight
- 0.80%
- Δ weight
- up 0.04 pts
- Value
- ₹36.7 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 0.67%
- Δ weight
- down 0.02 pts
- Value
- ₹31 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 0.57%
- Δ weight
- down 0.03 pts
- Value
- ₹26.1 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 0.48%
- Δ weight
- up 0.48 pts
- Value
- ₹21.9 Cr
- Δ value
- up ₹21.9 Cr
- Status
- New
- Weight
- 0.42%
- Δ weight
- down 0.01 pts
- Value
- ₹19.3 Cr
- Δ value
- down ₹60 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.31%
- Δ weight
- down 0.34 pts
- Value
- ₹14.2 Cr
- Δ value
- down ₹15.8 Cr
- Status
- Trimmed
- Weight
- 0.28%
- Δ weight
- up 0.01 pts
- Value
- ₹12.6 Cr
- Δ value
- up ₹19 L
- Status
- Added
What changed, Jul 2022 to Aug 2022
New New positions (1)
- GlaxoSmithKline Pharmaceuticals Limited0.5% · ₹21.9 Cr
Exited Exited (0)
None.
Added Biggest additions
- Zydus Lifesciences Limitedup ₹30.1 Cr (+0.67% pts)
- Cipla Limitedup ₹24.4 Cr (+0.59% pts)
- Lupin Limitedup ₹24.1 Cr (+0.57% pts)
- Ajanta Pharma Limitedup ₹23.2 Cr (+0.52% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2022, the weight rose most in Pharmaceuticals & Biotechnology (+0.2 pts), and fell most in Pharmaceuticals (−0.1 pts).
- Pharmaceuticals & Biotechnology80.4% → 80.6%+0.2 pts
- Pharmaceuticals1.5% → 1.4%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2021 | Feb 2022 | May 2022 | Jul 2022 | Aug 2022 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 73.6% | 75.8% | 79.9% | 80.4% | 80.6% |
| Healthcare Services | 23.7% | 21.8% | 17.7% | 17.4% | 17.4% |
| Pharmaceuticals | 2.2% | 2.0% | 1.8% | 1.5% | 1.4% |
| Healthcare Equipment & Supplies | — | 0.5% | 0.6% | 0.6% | 0.6% |
Allocation in Aug 2022change vs Jul 2022
- Pharmaceuticals & Biotechnology (19)80.6%▲ 0.2 pts
- Healthcare Services (7)17.4%▼ 0.1 pts
- Pharmaceuticals (1)1.4%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2022
0.3%
▼ 0.3 pts vs Jul 2022
- Cash alone
- 0.3%
- cash and net receivables
- A year earlier
- 4.7%
- Aug 2021 · now ▼ 4.4 pts
- Last 12 months
- 0.3% – 4.6%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.